| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Subunit, and Variable Circulating Thyrotropin (TSH) Levels as Hallmark of Central Hypothyroidism due to Mutations of the TSHß Gene1
Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore Istituto de Ricovero e Cura a Carattere Scientifico (M.B., P.B.-P.); Istituto Auxologico Italiano Istituto de Ricovero e Cura a Carattere Scientifico (L.P.); and Department of Pediatrics, University of Milan, H. S. Raffaele Istituto de Ricovero e Cura a Carattere Scientifico (M.C.P., G.W., G.C.), 20100 Milan, Italy
Address all correspondence and requests for reprints to: Luca Persani, M.D., Ph.D., Laboratorio di Ricerche Endocrinologiche, Istituto Auxologico Italiano IRCCS, Via Ariosto 13, 20145 Milan, Italy. E-mail: persani{at}auxologico.it
Inheritable isolated central hypothyroidism (ICH) due to mutations of
TSHß gene has been reported in few patients. For this reason the
diagnostic criteria are vague. The disorder is usually characterized by
undetectable TSH levels, although low/normal serum TSH, depending on
TSH measurement methods, has been documented in some patients. Here we
report an Egyptian girl with ICH due to a novel nonsense mutation of
the TSHß gene (Q49X). She was referred at 75 days of age for severe
clinical signs of hypothyroidism, whose central origin was documented
by normal serum TSH, low free T4 and free T3
levels, impaired TSH response to TRH, absence of 99Tc
thyroidal uptake, and antithyroid autoantibodies. Ultrasound revealed a
hypoplastic thyroid, whereas magnetic resonance imaging showed a
hyperplastic pituitary. All other pituitary hormones, including PRL,
were normally secreted. A diagnosis of idiopathic ICH was made, and
substitutive L-T4 treatment was started at 81
days of age. At the age of 7 yr the patient had normal thyroid hormone
levels, but was severely mentally retarded. Interestingly, the sella
computed tomography scan had completely normalized. At 8 yr of age the
patient was reinvestigated after 6-week L-T4
withdrawal. TSH values were highly variable depending on the
measurement method used, whereas extremely high levels of circulating
free glycoprotein
-subunit were recorded. Despite the fact that
mutant TSHß lacks 60% of the C-terminal amino acid sequence, it
forms with the
-subunit a heterodimer with preserved
immunoreactivity in some TSH measurement methods, but the mutant
heterodimer is completely devoid of bioactivity. In conclusion, high
circulating free glycoprotein
-subunit levels, variable TSH levels,
and, possibly, hyperplastic pituitary gland are the hallmark of ICH due
to mutations of the TSHß gene.
This article has been cited by other articles:
![]() |
American Academy of Pediatrics, S. R. Rose, and the Section on Endocrinology and Committee on, American Thyroid Association, R. S. Brown, and the Public Health Committee, and Lawson Wilkins Pediatric Endocrine Society Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, June 1, 2006; 117(6): 2290 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Borck, A. K. Topaloglu, E. Korsch, U. Martine, G. Wildhardt, N. Onenli-Mungan, B. Yuksel, U. Aumann, G. Koch, G. Ozer, et al. Four New Cases of Congenital Secondary Hypothyroidism due to a Splice Site Mutation in the Thyrotropin-{beta} Gene: Phenotypic Variability and Founder Effect J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4136 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brumm, A. Pfeufer, H. Biebermann, D. Schnabel, D. Deiss, and A. Gruters Congenital Central Hypothyroidism due to Homozygous Thyrotropin {beta} 313{Delta}T Mutation Is Caused by a Founder Effect J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4811 - 4816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pohlenz, A. Dumitrescu, U. Aumann, G. Koch, R. Melchior, D. Prawitt, and S. Refetoff Congenital Secondary Hypothyroidism Caused by Exon Skipping due to a Homozygous Donor Splice Site Mutation in the TSH{beta}-Subunit Gene J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 336 - 339. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |